Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Fused imidazopyridines as reversible inhibitors of Brutons Tyrosine Kinase (BTK)

Fused imidazopyridines as reversible inhibitors of Brutons Tyrosine Kinase (BTK)

US Patent 12415803 · Granted Sep 16, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Universal AC/DC current sensor and isolator2025
KRAS G12D proteolysis targeting chimeras2025
Antiproliferation compounds and uses thereof2025
Compounds and uses thereof2024
GCN2 inhibitors and uses thereof2024
Cannabinergic compounds and uses thereof2024
Labelled cannabinergic ligands and related analogs2023
Heteroaryl compounds as BTK inhibitors and uses thereof2021
Heteroaryl compounds as BTK inhibitors and uses thereof2021
Heteroaryl compounds as BTK inhibitors and uses thereof2021
Heteroaryl compounds as BTK inhibitors and uses thereof2021
Heteroaryl compounds as BTK inhibitors and uses thereof2021